AC

Anita Chandgothia

Active Director Director DIN 10548177
DIN 10548177 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Anita Chandgothia

Data last updated:

Anita Chandgothia is a Director at Ultrazeneca Private Limited (since 2024). The company operates in Pharma.

DIN 10548177
Primary Designation Director
Industry Pharma
First Appointment 13 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ultrazeneca Private Limited U46497WB2024PTC269135
Director13 Mar 20242024Active

Board colleagues of Anita Chandgothia

NameDINCompanyDesignation
Ankit Chandgothia08214710Ultrazeneca Private LimitedDirector
Jyoti Prakash10548176Ultrazeneca Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ultrazeneca Private Limited
Premium access

Shareholding and investment profile for Anita Chandgothia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Chandgothia

Anita Chandgothia currently holds 1 directorship: Ultrazeneca Private Limited (Director, since 13 Mar 2024).

Anita Chandgothia was first appointed on 13 Mar 2024 as Director at Ultrazeneca Private Limited.

The current boards of Anita Chandgothia's companies include Ankit Chandgothia (Ultrazeneca Private Limited), Jyoti Prakash (Ultrazeneca Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available